MHRA (Medicines & Healthcare Products Regulatory Agency) puts weight behind Boston stent recall:
This article was originally published in Clinica
Executive Summary
The number of products affected in the UK by the global recall of certain batches of Boston Scientific's Taxus Express2 paclitaxel-eluting stent system and Express2 bare metal stent system are 26,000 and 15,000, respectively. So says the device alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA) on July 23. The company has said that 85,000 and 11,000 units, respectively, were being recalled worldwide. UK healthcare providers have been issued with a July 29 deadline for receiving a recall notification from Boston. Failure to receive this will require that all products of these types be returned to the manufacturer.